• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[推进消费者循证健康信息开发标准:循证医学网络成员的需求与优先事项]

[Advancing standards for the development of evidence-based health information for consumers: Needs and priorities among members of the Network for Evidence-based Medicine].

作者信息

Büchter Roland Brian, Albrecht Martina, Grimm Michael, Seelig Markus, Steckelberg Anke, Rahn Anne Christin

机构信息

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), Köln, Deutschland; für den Fachbereich Patienteninformation und -beteiligung des EbM-Netzwerks.

SHARE TO CARE, Patientenzentrierte Versorgung GmbH, Köln, Deutschland.

出版信息

Z Evid Fortbild Qual Gesundhwes. 2024 Jun;187:42-52. doi: 10.1016/j.zefq.2024.03.011. Epub 2024 May 13.

DOI:10.1016/j.zefq.2024.03.011
PMID:38744602
Abstract

BACKGROUND

The Good Practice Guidelines for health information, Good Health Information Austria and Guideline Evidence-based Health Information are established resources for developing evidence-based health information in the German-speaking regions. The aim of this project was to capture challenges in applying these standards in practice, identify gaps and development needs and gain insights for their further development.

METHODS

In December 2020, members of the working group for patient information and involvement of the Network for Evidence-based Medicine were invited to share their experiences and needs in applying German standards for evidence-based health information through an online survey focussing on open questions (part 1: needs assessment). The feedback was analysed using qualitative content analysis and presented in a workshop at the EbM Congress 2021 with the goal of specifying the feedback from the needs assessment and discussing ideas for the further development of the standards (part 2: specification). In the final step, a second survey was conducted in February 2023 to prioritize the identified topics by the working group members (part 3: prioritization). The results were analysed descriptively.

RESULTS

Among the 41 participants, only 23% considered the standards to be sufficient, and only 55% found their application in the development of information to be easy or rather easy. The needs assessment and workshop (n=46) helped to identify various areas of action. With regard to the application of the standards, the following challenges were identified: lack of user orientation, content gaps, methods and risk communication. Gaps in the standards were identified regarding formats, content, and the connection to healthcare provision. For the advancement of the standards ideas for additional content, stakeholder involvement, and improvement of the usability of the standards were identified. In the prioritization survey, the topic areas, "presenting benefits and harms" and "content beyond treatments (in particular, diagnostics and prognosis)" were considered to be the most important (n=36).

DISCUSSION

Among members of the working group for patient information and involvement of the German Network for Evidence-based Medicine, a high demand has been identified for the further development of standards for creating evidence-based health information. In addition to content development, the integration of existing documents and tools should also be considered, including products issued by other institutions. The success of advancing the standards also depends on improving their applicability - for example through an attractive online platform. The results are limited by the sample which only included members of the EbM Network's patient information and participation working group and a limited response rate.

CONCLUSIONS

The needs assessment showed that the currently established standards and recommendations for the development of evidence-based health information in the German-speaking regions represent important cornerstones but need to be expanded to answer more practice-oriented questions. The challenges and proposed solutions stated by the participants can help further develop the standards. The prioritization can be used to set priorities for the development of the standards, guide the order of possible work packages and allocate resources.

摘要

背景

《健康信息良好实践指南》《奥地利健康信息》和《循证健康信息指南》是德语地区制定循证健康信息的既定资源。本项目的目的是了解在实践中应用这些标准所面临的挑战,识别差距和发展需求,并为其进一步发展获取见解。

方法

2020年12月,循证医学网络患者信息与参与工作组的成员受邀通过一项侧重于开放性问题的在线调查(第1部分:需求评估),分享他们在应用德语循证健康信息标准方面的经验和需求。使用定性内容分析法对反馈进行分析,并在2021年循证医学大会的一次研讨会上展示,目的是明确需求评估的反馈并讨论标准进一步发展的想法(第2部分:细化)。在最后一步,于2023年2月进行了第二次调查,以让工作组成员对已识别的主题进行优先级排序(第3部分:优先级确定)。对结果进行描述性分析。

结果

在41名参与者中,只有23%的人认为这些标准足够,只有55%的人发现在信息开发中应用这些标准容易或比较容易。需求评估和研讨会(n = 46)有助于确定各个行动领域。关于标准的应用,发现了以下挑战:缺乏用户导向、内容差距、方法和风险沟通。在标准方面,在格式、内容以及与医疗服务的联系方面发现了差距。为了推进标准,确定了关于额外内容、利益相关者参与以及提高标准可用性的想法。在优先级排序调查中,“呈现益处和危害”以及“治疗以外的内容(特别是诊断和预后)”这两个主题领域被认为是最重要的(n = 36)。

讨论

在德语循证医学网络患者信息与参与工作组的成员中,已确定对创建循证健康信息的标准进一步发展有很高需求。除了内容开发外,还应考虑整合现有文件和工具,包括其他机构发布的产品。推进标准的成功还取决于提高其适用性——例如通过一个有吸引力的在线平台。结果受到样本的限制,该样本仅包括循证医学网络患者信息与参与工作组的成员且回复率有限。

结论

需求评估表明,德语地区目前为循证健康信息开发制定的标准和建议是重要基石,但需要扩展以回答更多面向实践的问题。参与者提出的挑战和解决方案有助于进一步发展这些标准。优先级排序可用于为标准制定确定优先级,指导可能的工作包顺序并分配资源。

相似文献

1
[Advancing standards for the development of evidence-based health information for consumers: Needs and priorities among members of the Network for Evidence-based Medicine].[推进消费者循证健康信息开发标准:循证医学网络成员的需求与优先事项]
Z Evid Fortbild Qual Gesundhwes. 2024 Jun;187:42-52. doi: 10.1016/j.zefq.2024.03.011. Epub 2024 May 13.
2
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
[Good practice guidelines for health information].[健康信息的良好实践指南]
Z Evid Fortbild Qual Gesundhwes. 2016;110-111:85-92. doi: 10.1016/j.zefq.2015.11.005. Epub 2016 Jan 13.
5
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
6
[Needs assessment to improve the applicability and methodological quality of a German S3 guideline].[提高德国S3指南适用性和方法学质量的需求评估]
Z Evid Fortbild Qual Gesundhwes. 2018 Apr;131-132:1-7. doi: 10.1016/j.zefq.2017.09.002. Epub 2017 Sep 27.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
[Evidence-based medicine teaching activities in the German-speaking area: a survey].[德语区的循证医学教学活动:一项调查]
Z Evid Fortbild Qual Gesundhwes. 2013;107(1):5-12. doi: 10.1016/j.zefq.2012.12.005. Epub 2013 Jan 15.
9
[Development of criteria for the prospective assessment of the need for updating guideline recommendations: The AGIL criteria].[制定前瞻性评估指南建议更新需求的标准:AGIL标准]
Z Evid Fortbild Qual Gesundhwes. 2024 Mar;184:7-17. doi: 10.1016/j.zefq.2023.11.006. Epub 2024 Jan 18.
10
Cochrane Airways Group reviews were prioritized for updating using a pragmatic approach.科克伦航空集团的综述优先使用实用主义方法进行更新。
J Clin Epidemiol. 2015 Mar;68(3):341-6. doi: 10.1016/j.jclinepi.2014.11.002. Epub 2014 Nov 6.